Obesity Trends and Body Mass Index Changes After Starting Antiretroviral Treatment: The Swiss HIV Cohort Study. - Wikidata - awgldk - TriplyDB

Obesity Trends and Body Mass Index Changes After Starting Antiretroviral Treatment: The Swiss HIV Cohort Study.

Obesity Trends and Body Mass Index Changes After Starting Antiretroviral Treatment: The Swiss HIV Cohort Study.

http://www.wikidata.org/entity/Q34802246

about

Perspectives on pharmacogenomics of antiretroviral medications and HIV-associated comorbidities From Wasting to Obesity: The Contribution of Nutritional Status to Immune Activation in HIV Infection.The metabolic and cardiovascular consequences of obesity in persons with HIV on long-term antiretroviral therapy Changes in weight and weight distribution across the lifespan among HIV-infected and -uninfected men and women.Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D study.Practical Review of Recognition and Management of Obesity and Lipohypertrophy in Human Immunodeficiency Virus Infection.Obesity prevalence and related risk of comorbidities among HIV+ patients attending a New England ambulatory centre.HIV and ageing: improving quantity and quality of life.Higher Time-Updated Body Mass Index: Association With Improved CD4+ Cell Recovery on HIV Treatment.Adipose Tissue in HIV Infection.Aging metabolism: intervention strategies.HIV-Infected Women Gain More Weight than HIV-Infected Men Following the Initiation of Antiretroviral Therapy.

P2860

Q26853274-32AABD40-5893-4B7A-8A8F-E16713FCDB92 Q30245375-19575580-F52F-4175-8C34-304D5F93A247 Q36436780-1BBB2380-97B0-43FC-8A7D-840708F73F72 Q37433073-C67545A6-665C-4F84-BAE7-0815F3B26BB8 Q38413429-FA3E1149-4E13-45D0-B74A-581471BE639D Q38741518-F6507498-5A37-4C15-B0C6-86B29C401C32 Q38860829-401F0F9F-3986-4D79-A3B5-A93CF2F4A6DD Q38883328-8CCFC84C-9870-4DD9-851C-C1E7400BB998 Q39820692-E9A6BB11-D752-411B-9855-BF766B70FD0D Q40038736-AD0F8AAC-9D62-411D-9D7A-2613F9D44D2D Q40296763-7D288BEC-C76B-447E-A12D-16AACCAA91D7 Q52613761-D4FAF8CD-FEFE-4CBC-8C1A-59961A3D9C4A

P2860

Obesity Trends and Body Mass Index Changes After Starting Antiretroviral Treatment: The Swiss HIV Cohort Study.

http://www.wikidata.org/entity/Q34802246

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Obesity Trends and Body Mass I ...... t: The Swiss HIV Cohort Study.

@ast

Obesity Trends and Body Mass I ...... t: The Swiss HIV Cohort Study.

@en

Obesity Trends and Body Mass I ...... t: The Swiss HIV Cohort Study.

@nl

type

label

Obesity Trends and Body Mass I ...... t: The Swiss HIV Cohort Study.

@ast

Obesity Trends and Body Mass I ...... t: The Swiss HIV Cohort Study.

@en

Obesity Trends and Body Mass I ...... t: The Swiss HIV Cohort Study.

@nl

prefLabel

Obesity Trends and Body Mass I ...... t: The Swiss HIV Cohort Study.

@ast

Obesity Trends and Body Mass I ...... t: The Swiss HIV Cohort Study.

@en

Obesity Trends and Body Mass I ...... t: The Swiss HIV Cohort Study.

@nl

P1433

Q34802246-92156296-D83C-4DDC-B1BB-98E6CAA869F6

P1476

Q34802246-3CE80F86-F4C9-435B-8001-AE5D1C0013C5

P2093

Q34802246-0756AC71-F4E8-40BB-AE6F-8F0856C7176E

Q34802246-0A060A69-397C-4CAF-B634-D7D302FC7E82

Q34802246-0BF4E3BB-1871-486C-8773-DDFB0A5EB677

Q34802246-1B7D9390-D483-40A2-ABF1-E44A5C7849C1

Q34802246-1E437F00-6229-4EC9-A1AE-FEE14E94DA38

Q34802246-21A90470-98C0-43E9-BEA4-C420DC34235C

Q34802246-233F1A8C-E43B-4C38-BAAE-575F07422933

Q34802246-2C75F88C-98B3-473D-9B78-45D616290793

Q34802246-2E4E8BB0-042D-494A-B575-9A287C29733E

Q34802246-2E7F40A2-973F-451B-B5B5-0472A5F6E30F

P2860

Q34802246-023B4852-9527-46D9-A907-833F8FF1D10D

Q34802246-0AF87ED5-13C0-42BE-8C95-C66AE51BAC1A

Q34802246-1751C778-CCD4-4ADA-9EDD-B011022CDB2D

Q34802246-1980EE42-4E57-4D23-80D8-A55C82CC3A66

Q34802246-1B36F671-4F0E-4641-BD75-9619FC8909EA

Q34802246-1FCD1690-823A-4175-9CC8-E0BECD5320D2

Q34802246-27A6B239-2B69-4FD3-A79C-5DC53BB56844

Q34802246-3B132EEE-B820-4AB1-8E63-A4DA19C60E25

Q34802246-3F24E3AC-AFBA-4DB5-AE82-42549774604C

Q34802246-40C9A6B5-BE6E-4729-9869-FF547B16C353

P304

Q34802246-2CBB33D6-57CE-472A-8447-2BFDF30817B5

P31

Q34802246-2452613A-12FF-4A23-9CAE-514DFF0A177D

P356

Q34802246-DF563AD4-E2FA-413E-827A-E1AE3B91CF5C

P433

Q34802246-8FA2A2CB-F094-40A4-B966-5054F9484A12

P478

Q34802246-05AAE82C-1930-49F1-9825-C2E4C6A75529

P50

Q34802246-19D6BA4D-10C3-46B1-BF43-AB1A48AA0068

Q34802246-52BC49B6-7FD7-497E-8037-C29C392924DD

Q34802246-55CFBE96-3437-4875-9314-657E31499265

Q34802246-6FF75DDC-BE5A-4171-86B4-0EA9F70D70F7

Q34802246-735D4A8C-59FD-4D62-A717-95697099548E

Q34802246-78821A1B-607C-4B9F-AC5B-15EDB3A8DC19

Q34802246-F4730EA2-3C43-4451-BD6B-4568DC879E0B

P577

Q34802246-8C1B403D-951E-44B5-9A41-36ED567D9C0E

P5875

Q34802246-68DD23CC-1E43-4156-833E-4AE81C7C5C9F

P698

Q34802246-47767F19-4C68-480B-8CD5-3F9F2E3DD255

P921

Q34802246-9BE6C9FA-B931-400E-8D1F-56B12B76E20D

Q34802246-D5072EF7-65BE-40DA-86ED-50CAD428E0D0

P932

Q34802246-7511467C-7E8D-4A1D-8172-F658B70402D4

P356

P1433

Open forum infectious diseases

P1476

Obesity Trends and Body Mass I ...... t: The Swiss HIV Cohort Study.

@en

P2093

A Calmy

http://www.w3.org/2001/XMLSchema#string

A Rauch

http://www.w3.org/2001/XMLSchema#string

A Telenti

http://www.w3.org/2001/XMLSchema#string

A Trkola

http://www.w3.org/2001/XMLSchema#string

B Hasse

http://www.w3.org/2001/XMLSchema#string

B Ledergerber

http://www.w3.org/2001/XMLSchema#string

B Martinez de Tejada

http://www.w3.org/2001/XMLSchema#string

Barbara Hasse

http://www.w3.org/2001/XMLSchema#string

Bruno Ledergerber

http://www.w3.org/2001/XMLSchema#string

C A Fux

http://www.w3.org/2001/XMLSchema#string

P2860

The Influence of Smoking Cessation on the Prevalence of Overweight in the United States

HIV infection and the risk of acute myocardial infarction.

Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis

Increasing rates of obesity among HIV-infected persons during the HIV epidemic

Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010

Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies

Lipodystrophy and weight changes: data from the Swiss HIV Cohort Study, 2000-2006.

Prevalence and correlates of elevated body mass index among HIV-positive and HIV-negative women in the Women's Interagency HIV Study.

Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy.

CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.

P304

ofu040

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/OFID/OFU040

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P50

Enos Bernasconi

Alexandra Calmy

Swiss HIV Cohort Study

Christoph Hauser

Matthias Cavassini

Manuel Battegay

P577

2014-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273153111

http://www.w3.org/2001/XMLSchema#string

P698

25734114

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

4281814

http://www.w3.org/2001/XMLSchema#string